Common Contracts

AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: ADURO BIOTECH, INC., a Delaware corporation; ASPIRE MERGER SUB, INC., a Delaware corporation; and CHINOOK THERAPEUTICS U.S., INC., a Delaware corporation Dated as of June 1, 2020

Agreement and Plan of Merger and Reorganization • June 2nd, 2020 • Aduro Biotech, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Agreement and Plan of Merger and Reorganization
• Filed
  June 2nd, 2020
• Company
  Aduro Biotech, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made and entered into as of June 1, 2020, by and among ADURO BIOTECH, INC., a Delaware corporation (“Parent”), ASPIRE MERGER SUB, INC., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), and CHINOOK THERAPEUTICS U.S., INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.

AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: TOCAGEN INC., a Delaware corporation; TELLURIDE MERGER SUB, INC., a Delaware corporation; and FORTE BIOSCIENCES, INC., a Delaware corporation Dated as of February 19, 2020

Agreement and Plan of Merger and Reorganization • February 20th, 2020 • Tocagen Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Agreement and Plan of Merger and Reorganization
• Filed
  February 20th, 2020
• Company
  Tocagen Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made and entered into as of February 19, 2020, by and among Tocagen Inc., a Delaware corporation (“Parent”), Telluride Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), and Forte Biosciences, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.

AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: CONATUS PHARMACEUTICALS INC., a Delaware corporation; CHINOOK MERGER SUB, INC., a Delaware corporation; and HISTOGEN INC., a Delaware corporation Dated as of January 28, 2020

Agreement and Plan of Merger and Reorganization • January 28th, 2020 • Conatus Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Agreement and Plan of Merger and Reorganization
• Filed
  January 28th, 2020
• Company
  Conatus Pharmaceuticals Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made and entered into as of January 28, 2020, by and among CONATUS PHARMACEUTICALS INC., a Delaware corporation (“Parent”), CHINOOK MERGER SUB, INC., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), and HISTOGEN INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.